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Abstract
Background: Cryopreservation of peripheral blood mononuclear cells has been used to preserve and
standardize immunologic measurements for multicenter studies, however, effects of cryopreservation on
cytokine responses are incompletely understood. In designing immunologic studies for a new multicenter birth
cohort study of childhood asthma, we performed a series of experiments to determine the effects of two different
methods of cryopreservation on the cytokine responses of cord and peripheral blood mononuclear cells.
Results: Paired samples of PBMC were processed freshly, or after cryopreservation in a Nalgene container (NC)
or a controlled-rate freezer (CRF). Although there were some differences between the methods,
cryopreservation inhibited PHA-induced IL-10 secretion and Der f 1-induced IL-2 secretion, and augmented PHA-
induced IL-2 secretion and spontaneous secretion of TNF-α. In separate experiments, NC cryopreservation
inhibited secretion of several cytokines (IL-13, IL-10, IFN-γ, TNF-α) by PHA-stimulated cord blood mononuclear
cells. With the exception of PHA-induced IL-13, results from fresh and cryopreserved cord blood samples were
not significantly correlated. Finally, in reproducibility studies involving processing of identical cell samples in up to
4 separate laboratories, variances in cytokine responses of fresh cells stimulated at separate sites did not exceed
those in cryopreserved cells stimulated at a central site.
Conclusion: Collectively, these studies indicate that cryopreservation can affect mononuclear cell cytokine
response profiles, and that IL-10 secretion and antigen-induced responses may be especially vulnerable. These
studies also demonstrate that mononuclear cell responses can be standardized for performance in a small number
of laboratories for multicenter studies, and underscore the importance of measuring reproducibility and of testing
whether cryopreservation techniques alter specific immunologic outcomes.
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With the increase in multi-center studies has come an
increased need to perform cellular studies that can be
standardized. The responses of blood mononuclear cells
are commonly used as surrogates for in vivo immune
responses to adaptive and innate immune stimuli. Per-
forming cellular assays at a single central laboratory by the
use of cryopreserved and shipped specimens is generally
thought to improve their feasibility and uniformity. This
approach has been used extensively in vaccine and tumor
immunology research, and several methodological inves-
tigations on the use of cryopreserved cells demonstrate
preserved viability, as well as preserved functional
responses such as proliferation and the frequency of
cytokine producing cells – particularly to class I-restricted
antigens [1-7]. In contrast, others have reported some loss
of function in cryopreserved cells [8-10].
As part of the NIAID-sponsored Inner City Asthma Con-
sortium, the Urban Environment & Childhood Asthma
(URECA) investigation is a birth-cohort study examining
the relationship between innate and adaptive immune
responses, including responses to allergens, and the devel-
opment of allergic asthma. There are four URECA clinical
sites located in Baltimore, Boston, New York and St.
Louis.
Few studies comparing the immunologic responses of
fresh and cryopreserved mononuclear cells specifically
examined responses to allergens and even fewer have
assessed the impact of cryopreservation on the functional
outcome of cytokine secretion [11]. Furthermore, as one
of the primary benefits of centralization is thought to be
decreased assay variability, we wished to directly compare
assay variability using a 'peripheral lab' model in which
each site obtains and stimulates freshly isolated mononu-
clear cells to that of a 'central lab' model, in which cells are
locally cryopreserved and then shipped to a central site for
stimulation assays.
We found that the response of cryopreserved peripheral
blood mononuclear cells (PBMC) and cord blood mono-
nuclear cells (CBMC) may not correlate with those of
fresh cells. We also found that by careful standardization
of laboratory procedures across participating laboratories,
variability within the peripheral lab model is not different
from that of the central lab model. These findings indicate
the need to carefully evaluate effects of cryopreservation
on immunologic outcomes and demonstrate that use of
freshly isolated cells is a viable alternative for multicenter
studies.
Results
Cytokine secretion of mitogen and antigen stimulated 
PBMC before and after cryopreservation
We first compared secretion of a panel of cytokines from
cryopreserved and fresh atopic and non-atopic donor
PBMC to innate (lipopolysaccharide [LPS]), polyclonal
(phytohemaglutinin [PHA]) and adaptive (Der f 1, Bla g
2) immune cell stimuli in order to evaluate whether these
responses are adequately preserved in cryopreserved cells.
Accumulated IFN-γ, TNF-α, IL-10, IL-4, IL-5 and IL-2 were
measured at several time points from supernatants of sep-
arate, parallel cultures (Additional File 1). LPS induced
strong IL-10, TNF-α and IFN-γ responses that tended to
peak on days 1 or 2. PHA strongly induced IFN-γ, TNF-α
and IL-10, and lesser levels of IL-2 and IL-5. The major
dust mite allergen, Der f 1, induced IL-2, TNF-α and IL-5
in some individuals. These responses were maximal on
day 7. Responses to Bla g 2 were obscured by heavy endo-
toxin contamination and were not analyzed further.
There were significant differences in cytokine secretion
between fresh and cryopreserved cells for a number of
stimulants (Additional File 1), and several responses
appeared to be blunted. For example, PHA-induced IL-10
was approximately four to five-fold lower from cells cryo-
preserved using either of two methods. PHA-induced IL-
10 peaked at day two with responses of 368 and 1,200 pg/
ml (geometric means, p < 0.001) for Nalgene-preserved
and fresh PBMC respectively. Cryopreservation in a con-
stant rate freezer (CRF) produced similar effects. IL-10
responses to Der f 1 also were diminished by either
method of cryopreservation (Figure 1A). LPS-induced IL-
10 secretion was strongly blunted in Nalgene preserved
PBMC, though this was not consistently seen in the CRF
preserved cells.
In contrast, some responses were consistently increased in
cryopreserved cells. Unstimulated PBMC cryopreserved by
either method produced significantly greater (5–6 fold)
amounts of TNF-α than fresh PBMC, although levels were
low (<40 pg/ml) for all methods (Additional File 1). IL-2
secretion from PHA-stimulated cells was significantly
greater in Nalgene PBMC (~10 fold), and the same effect
(increase of 3–4 fold), was seen in the constant rate pre-
served cells (Figure 1B).
Quantitative differences in cytokine secretion between
fresh and cryopreserved cells may be acceptable if there is
a predictable bias and qualitative differences are pre-
served. We therefore examined the correlation between
stimulated fresh and cryopreserved cells. We assessed the
quantitative differences between the different methods
using two approaches: the Pearson correlation (rho) and
the concordance correlation coefficient (CCC) [12]. The
Pearson correlation measures a linear relationship, andPage 2 of 12
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ment between the two methods. As seen from representa-
tive scatter plots of secreted cytokine from fresh vs.
cryopreserved cells from the same individuals stimulated
with PHA (IL-10; Fig. 2A,C) or Der f 1 (IL-2; Figure 2B,D)
there was generally poor concordance (CCC from 0.06 to
0.18 for PHA-induced IL-10 and 0.06 to 0.2 for Der f-
induced IL-2, p < 0.05 only for CRF preserved PHA-
induced IL-10) though for Nalgene preserved Der f-
induced IL-2 and CRF preserved PHA-induced IL-10, there
was statistically significant Pearson correlation (rho = 0.3
and 0.6, respectively). Poor correlation was also observed
for other significantly affected responses, including PHA-
induced IFN-γ, TNF-α, IL-5, IL-4 and IL-2 (Additional File
1).
Not all responses were altered as strongly. In particular,
LPS-induced IFN-γ at both 10 and 100 ng doses were rel-
atively well preserved with small differences only at some
time points and good overall correlation (Additional File
1). However, the majority of measurable responses to
PHA, LPS and allergens were significantly altered with
poor correlation between fresh and cryopreserved cells.
Effects of cryopreservation on cytokine secretion from LPS 
and PHA stimulated CBMC
We next compared the responses of fresh and cryopre-
served cord blood mononuclear cells (CBMC). Freshly
isolated CBMC secreted significant amounts of IFN-γ,
TNF-α, IL-10 and IL-12 p40 in response to LPS (Addi-
tional File 2). Cryopreservation inhibited LPS-induced IL-
10, IL-12 p40 and TNF-α (Figure 3A, B and 3C, respec-
tively), and similar effects were noted for IFN-γ (data not
shown). Cryopreservation also significantly inhibited
PHA-induced IL-10, IL-13 and IFN = γ (Figure 3D, E and
3F).
Next, we analyzed the dataset to determine whether cryo-
preservation altered cytokine responses in a predictable
fashion. In general, there was weak agreement between
the fresh and cryopreserved cells with concordance corre-
lations between -0.52 (-0.87 to 0.16; 95% confidence
interval) for PHA-induced IFN-γ (Fig. 3F), and 0.19 (-0.06
to 0.42) for PHA-induced IL-13 (Fig. 3E). There were also
no significant Pearson correlations between fresh and cry-
opreserved cell responses, although PHA-induced IL-13
from either fresh or preserved cells showed a trend toward
linearity (rho = 0.55; -0.13 to 0.88, Fig. 3E).
Finally, we examined the reproducibility of cytokine
secretion when cells are stimulated fresh, or following cry-
opreservation (Figure 4). The reproducibility between rep-
licate cultures of fresh cells for LPS-induced IL-10 (CCC =
0.93 [0.74 – 0.98], A), PHA-induced IL-10 (CCC = 0.99
[0.96 – 1.00], B) and LPS-induced IL-12 p40 (CCC = 0.96
[0.91 – 0.98], C) was strong. There was lower concord-
ance, however, between replicate cultures of cryopre-
served cells (CCC = 0.58 [-0.06 – 0.88], 0.37 [-0.12 – 0.72]
Effect of cryopreservation on PBMC secretion of IL-10 and IL-2Figure 1
Effect of cryopreservation on PBMC secretion of IL-10 and IL-2. Mean response ratios were calculated for IL-10 (A) 
and IL-2 (B) for cells cryopreserved with either the Nalgene or constant rate freezer methods. Whiskers represent the 95% 
confidence intervals for difference. See methods for details of statistical analysis.
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Effect of cryopreservation on PBMC cytokine responsesFigure 2
Effect of cryopreservation on PBMC cytokine responses. Data points represent cytokine responses by the same sub-
jects' PBMC either cultured fresh or after cryopreservation. A, C. cells were stimulated for Each data point represents the 
comparison of the same subject at the same time point. Data shown include up to 3 time points per subject. The dotted line 
represents perfect agreement or concordance, and the solid line is best fit to data. Rho = Pearson correlation; CCC = Con-
cordance Correlation Coefficient. See methods for details of statistical analysis. * p < 0.05; ** p < 0.01; ***p < 0.001.
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induced IL-10 and LPS-induced IL-12 p40, respectively,
D-F).
Performance of fresh vs cryopreserved mononuclear cells 
in a multicenter study
Although these data demonstrate that cryopreservation
can affect PBMC cytokine secretion, cryopreservation and
central laboratory cellular stimulation in the context of a
multi-site study could minimize site-to-site variability,
and this might outweigh disadvantages related to cryop-
reservation. In order to address this, we conducted a
reproducibility study between the four URECA study sites
and a central laboratory.
On three separate occasions, blood from a single donor
was collected, diluted 1:1 in RPMI, and transported to
each site via commercial aircraft. Once received, half of
the cells were stimulated (PHA, LPS, and tetanus toxoid
[TT]) within 16 hours from the time of the blood draw
(Figure 5). The other half were cryopreserved, shipped to
the central laboratory, thawed and then stimulated in an
identical fashion. Both the fresh and cryopreserved cells
were processed in duplicate so that the variability of each
protocol could be determined. This experimental design
allowed us to directly address variability due to perform-
ance of stimulation assays at multiple sites versus the var-
iability of the assay at a central site after cryopreservation.
Cell recovery (mean 66%; range [49–77%]) and viability
(mean 94.3%; [92.5–98%]) after cryopreservation were
not significantly different between sites (not shown).
Consistent with what was seen in the previous experi-
ments, cytokine secretion was altered in cryopreserved
cells (Table 1). For example, IL-10 responses were gener-
ally suppressed (Table 1 and Fig. 6C). PHA-induced IFN-γ
and TNF-α secretion also were both significantly blunted
(5 fold and 2 fold lower, respectively, Table 1), as was TT-
induced IFN-γ (8-fold lower in preserved vs. fresh cells;
Fig. 6A and Table 1).
Next, the variances of duplicate samples were compared
for the two processing protocols. Only three comparisons
of variances were found to be statistically different when
Effect of cryopreservation on CBMC cytokine responsesFigure 3
Effect of cryopreservation on CBMC cytokine responses. Data points represent cytokine responses by the same sub-
jects' CBMC either cultured fresh or after cryopreservation. The dotted line represents perfect agreement or concordance, 
and the solid line is best fit to data. Rho = Pearson correlation; CCC = Concordance Correlation Coefficient. See methods for 
details of statistical analysis. * p < 0.05; **p < 0.01; ***p < 0.001.
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ods: PHA-induced IL-10, LPS-induced IL-12, and TT-
induced IL-10 (Table 1). For all three, there was greater
variability in the centrally cultured cells that had been cry-
opreserved than in the fresh cells cultured at separate sites.
Discussion
The Urban Environment and Childhood Asthma
(URECA) study is investigating the relationship between
early childhood exposures to allergens and viral infections
and the development of asthma. Mononuclear cell
cytokine responses to environmental antigens will be
assessed over the first three years of life in a cohort of chil-
dren at high risk for the development of asthma. The pilot
studies reported here addressed the feasibility and opti-
mal methodology for performance of those cellular
assessments.
Assay standardization and inter-site variability are of great
importance for multicenter studies. Several studies have
documented substantial inter-site variation in assessing
PBMC viability and responses following cryopreservation
and shipment. For example, in a recent study comparing
variability in cellular assays 20 × 106 cells were shipped
from a central lab to 11 different sites. Cell recovery at
those sites ranged from 4.7% to 114%. The viability
ranged from 24.8% to 100% and coefficients of variation
for HIV-1-specific IFN-γ secreting cells (spot forming cells
per 106) ranged from 36%–256% [13]. While the results
from these laboratories were consistent with respect to
internal ranking of responses (i.e. low, moderate, or
high), a direct quantitative comparison between laborato-
ries was not possible.
Since direct comparisons of quantitative measurements
are essential for our multi-site study, we assessed multiple
approaches to minimize variability. To quantify variabil-
ity we measured cytokine production from cord blood
and peripheral cells that were isolated and stimulated
fresh with a panel of innate and adaptive stimulants, at
Reproducibility of cytokine responses of fresh vs. cryopreserved cellsFigure 4
Reproducibility of cytokine responses of fresh vs. cryopreserved cells. Data points represent cytokine responses 
from replicate PBMC cultures. The dotted line represents perfect agreement or concordance, and the solid line is best fit to 
data. Rho = Pearson correlation; CCC = Concordance Correlation Coefficient. See methods for details of statistical analysis. * 
p < 0.05; ** p < 0.01; *** p < 0.001.
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Four-site reproducibility study designigure 5
Four-site reproducibility study design.
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BMC Immunology 2006, 7:29 http://www.biomedcentral.com/1471-2172/7/29each laboratory (peripheral lab model). These results were
then compared to the results obtained using the same
donor's cells that were isolated and preserved at each site
and then shipped to a central lab where they were thawed
and stimulated by an identical panel of stimulants (cen-
tral lab model). Techniques for cell isolation, cell stimula-
tion and cryopreservation, and all reagents were carefully
standardized.
Reproducibility of cytokine responses in central vs. peripheral processing protocolsFigure 6
Reproducibility of cytokine responses in central vs. peripheral processing protocols. Cytokine responses from 
PHA, TT and LPS stimulated cells cultured at each local site as fresh cells or cultured centrally following cryopreservation and 
shipment from local sites. Units are pg/ml. Three separate experiments are shown as runs 1–3.
A.    TT−induced IFN−γ
1
10
100
1000
10000
100000
Fresh Cryopreserved
●●●
Run 1
1
10
100
1000
10000
100000
● ●
●●
Run 2
1
10
100
1000
10000
100000
●●
●●
Run 3
BAL BOS MAD NY STL●
B.    LPS−induced TNF−α
1
10
100
1000
10000
Fresh Cryopreserved
●
●●
Run 1
1
10
100
1000
10000
●●●
Run 2
1
10
100
1000
10000
●●●
●
Run 3
C.    PHA−induced IL−10
1
10
100
1000
Fresh Cryopreserved
●
●
●
●
Run 1
1
10
100
1000
●
●
●
Run 2
1
10
100
1000
● ●
●
Run 3
D.   PHA−induced IL−13
1
10
100
1000
Fresh Cryopreserved
●
●●
Run 1
1
10
100
1000
●●
●●
Run 2
1
10
100
1000
●●
●
Run 3
Table 1: Comparison of PBMC cytokine secretion using central versus peripheral laboratory study models
IL-5a IL-13a TNFa IFN-γa IL-10a IL-8b IL-12a
PHA
- Peripheral lab (fresh) 26 (8.7) 422* (1.9) 4,400* (3.0) 73,000* (1.4) 557* (0.9#)
- Central lab (cryopreserved) 19 (8.0) 252* (3.3) 2,100* (2.0) 15,000* (4.0) 38* (7.1#)
LPS
- Peripheral lab (fresh) 2,600* (1.3) 68 (10) 981* (2.7) 332* (1.9) 7.9 (9.9#)
- Central lab (cryopreserved) 1,600* (5.2) 117(15) 708* (3.1) 141* (1.9) 6.6 (24#)
TT
- Peripheral lab (fresh) 8.2 (6.0) 555 (5.3) 493* (13) 81,400* (8.8) 24* (3.1#)
- Central lab (cryopreserved) 7.2 (26) 714 (2.5) 103* (1.4) 10,900* (1.6) 7* (20#)
Values are geometric mean (apg/ml, bng/ml); Percent coefficient of variation shown in parentheses. Red color and * indicates <0.01 for difference in 
cytokine produced between fresh v. cryopreserved PBMC; Blue color and # indicates <0.05 for difference in variancePage 8 of 12
(page number not for citation purposes)
BMC Immunology 2006, 7:29 http://www.biomedcentral.com/1471-2172/7/29Using this approach, we determined that cytokine
responses from cryopreserved mononuclear cells were sig-
nificantly different from those of fresh cells. Cryopreserva-
tion reduced IL-10 secretion by PBMC in response to PHA,
LPS or antigen (Der f 1) and also reduced IL-10 secretion
from PHA- and LPS-stimulated CBMC. Suppression of
PHA-induced IL-10 has been reported previously [14].
The strong and consistent suppression of IL-10 secretion
from cryopreserved cells, even while other responses are
preserved or enhanced, suggests that specific cellular sub-
sets may be affected more strongly by cryopreservation.
Some reports have suggested that antigen-presenting cells
may be such a subset, [9,15,16] and several PBMC subsets
with APC function may be potent producers of IL-10
including DCs, monocytes and B cells. Additionally, regu-
latory T cells may be an important source of IL-10 in these
cultures and may have differential sensitivity to cryop-
reservation [17].
We next conducted a reproducibility study using cells
from a single donor that were shipped to multiple sites.
Protocols and reagents for the five sites had been stand-
ardized and all personnel had attended centralized train-
ing to minimize variability. Using this approach we
demonstrated that with careful preparation and training,
inter-lab variability was more similar in fresh cells proc-
essed in multiple laboratories than using centralized
processing of cryopreserved cells in a single laboratory.
Many study designs seek to minimize variation by per-
forming cellular assays at a single central laboratory using
cells that are locally obtained, and shipped, usually after
cryopreservation. This approach is valid so long as cryop-
reserved cell responses show a reasonable correlation with
those of fresh cells. Several reports comparing fresh and
cryopreserved PBMC responses have shown that some
responses remain intact. Reimann et al. found that fewer
than 10% of 27 PBMC samples lost proliferative
responses to a panel of mitogens (PHA and PWM) and
recall antigens (TT and Candida). Cryopreserved PBMC
from renal carcinoma patients have been shown to retain
proliferative capacity to IL-2, capacity to generate cytolytic
activity, and secretion of PHA-induced IFN-γ. Both of
these studies were conducted at a single site and did not
address the potentially deleterious impact of shipment
and/or dry ice.
Some of the differences among experimental results
obtained using cryopreserved cells are likely due to differ-
ences in techniques, protocols, and reagents that have
been employed in different studies. For example, Disis et
al. evaluated effects of storage on dry ice, specific media
additives, and temperature at thawing on viability of cry-
opreserved PBMC [18]. In this study, cell viability was
adversely affected by use of human AB serum in the media
and by thawing of cells at 4°C rather than 25° or 37°C.
For our study, several lots of AB serum were screened for
effects on viability, and the viability of our cryopreserved
samples was consistently above 90%. Nevertheless, we
acknowledge that there may to be steps and/or reagents in
our protocol that could be improved so that deleterious
effects on PBMC cytokine responses could be lessened or
even eliminated. The results of our own study, and previ-
ous studies, should be interpreted with the understanding
that the protocols and technical details of both the cryop-
reservation protocol and the immunologic assays could
influence comparability of results obtained using fresh vs.
cryopreserved cells.
Similar to our study, several investigators have found
blunted responses from cryopreserved cells, particularly
to class II-restricted antigens. Weinberg et al.  found that
cryopreservation blunted proliferative responses to some
antigens TT and Candida, but not others (CMV and vari-
cella-zoster virus) [19]. This may be due to a selective
impact of cryopreservation on specific populations of
antigen-presenting cells. This concept is supported by data
from Maecker et al. who found that PBMC responses to
pooled peptides were superior to whole antigen.
Data are quite limited regarding the effects of cryopreser-
vation on allergen-induced cytokine secretion. A small
study of four patients found that IFN-γ, IL-2, IL-4 and IL-
5 responses to a panel of antigens, including grass and
dust allergens, were maintained in cryopreserved cells .
However, these authors compared cytokine response by
ELISPOT, and the analysis of allergen-specific responses
was limited to a single subject.
Conclusion
Based on our data, we have adopted the peripheral labo-
ratory model for the URECA study. Our results indicate
that with centralized training and standardized reagents
and protocols, inter-laboratory variability of cytokine
secretion assays at our four clinical sites could be reduced
to levels comparable or better to that obtained using cry-
opreserved cells and central processing. This approach
also eliminates alterations of cytokine response profiles
created by our method of cryopreservation. Collectively,
these findings underscore the need to carefully assess the
effects of cryopreservation, processing protocols and ship-
ment of cellular specimens on specific outcomes of inter-
est.
Methods
Standardization procedures
All reagents were purchased in bulk. After dose response
experiments of the stimuli were completed, single-use
aliquots for the entire study were frozen (-80°C) and
shipped to each site laboratory on dry ice. UniformPage 9 of 12
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sumable reagents, and sites used the same model centri-
fuge (Allegra 50, Beckman). Quality control procedures
were established for calibration and maintenance of incu-
bators (CO2 and temperature) centrifuges, pipettes, refrig-
erators and freezers.
Standard procedures were developed for cell isolation and
stimulation for cytokine production. Two training ses-
sions were held: head technicians from each of the clinical
sites reviewed and practiced the cell separation and cryo-
preservation procedures in February 2004, and in May
2005 lead technicians and immunologists practiced the
cell separation, cryopreservation and cell stimulation pro-
cedures. Performance criteria were developed for cell yield
and viability, and all technicians were certified in these
techniques.
Study subjects
The study subjects who donated blood for pilot studies
(Figures 1, 2; Additional File 1) were healthy volunteers.
CBMC samples were from the first 10 subjects recruited to
the URECA study (Figures 3, 4). Each of these children
had at least one allergic parent, lived in urban neighbor-
hoods selected for low socioeconomic status, and were
free from congenital anomalies or respiratory distress at
birth. The reproducibility experiments involving each of
the study center laboratories were carried out using PBMC
from a single non-allergic healthy normal volunteer (Fig-
ure 6; Table 1). All study subjects or their surrogates gave
written informed consent and the ethical review boards at
each institution approved all studies.
Isolation and cryopreservation of mononuclear cells
Mononuclear cells were obtained from peripheral or cord
blood by density gradient separation. Whole blood was
diluted 1:1 with RPMI containing heparin at the time of
collection and this was overlaid on Ficoll Paque Plus
(Amersham Biosciences) using Accuspin tubes (Sigma).
Cells were washed with PBS containing 1% human AB
serum.
The cryopreservation procedure was adapted from a pro-
tocol developed by the Immune Tolerance Network, and
was kindly provided by Dr. Jeff Bluestone. Washed mono-
nuclear cells were gently resuspended in human AB serum
at room temperature to a concentration of 2 × 107/mL.
The serum used in these experiments was prescreened for
its capacity to preserve cell viability and PHA-induced
IFN-γ responses in preliminary experiments. An equal vol-
ume of 20% DMSO in human AB serum was slowly added
(over approximately two minutes) to bring cells to 1 ×
107/mL. These were then transferred to isopropanol-con-
taining freezing containers (Nalgene) at room tempera-
ture and placed in a -80°C freezer for storage pending
transfer to dry ice for shipment to the central laboratory.
During pilot studies we also compared the use of a con-
stant rate freezer (Thermo) programmed to -1°C/hour
from room temperature to -80°C, after which cells were
shipped as above on dry ice.
Cell stimulation assays
Following isolation from whole blood, fresh mononu-
clear cells were resuspended in AIM-V media (Invitrogen
Corp., Carlsbad, CA) at a concentration of 4 × 106 cells/
ml. Cryopreserved mononuclear cells were quick-thawed
in a 37°C water bath until a small piece of ice remained
and then transferred to a 15 ml tube. Cold RPMI media
was slowly added drop-wise, mixing with each addition,
to a volume of 10 ml. Cells were centrifuged at 300 × g for
10 minutes, washed with 10 ml RPMI, counted by dye
exclusion with trypan blue for viability and resuspended
in AIM-V media at a concentration of 4 × 106 cells/ml.
To 5 ml culture tubes, 250 μl (1 × 106 cells) of either fresh
or thawed mononuclear cell suspension was added. Stim-
ulants were then added to each tube (250 μl) at the fol-
lowing final concentrations: 15 μg/ml PHA; 100 or 10 ng/
ml LPS (including 5% human AB serum); 10 μg/ml Der f
1, 10 μg/ml Bla g 2, 10 μg/ml tetanus toxoid (TT). AIM-V
medium (250 μl) was added to control cultures. Sufficient
quantities of stimulants were prepared from single lots at
the central laboratory, shipped to each laboratory, and
stored at -80°C until used. Based on kinetics of responses
shown in the pilot PBMC studies, CBMC and reproduci-
bility experiments were cultured for 1 day (PHA, LPS, and
media control) or 5 days (TT and media control) at 37°C
in a 5% CO2 humidified incubator. Tubes were centri-
fuged at 400 × g for 10 minutes, and supernatants were
aliquoted and stored at -80°C.
Four site reproducibility studies
To monitor the performance of procedures in the URECA
laboratories, a four-site reproducibility study was per-
formed on 3 separate occasions (Figure 5). For this study,
a single aliquot of blood (~160 mL) was drawn from a
volunteer, and was mixed with an equal volume of RPMI.
This mixture was divided into 40 mL aliquots, and two
aliquots each were packed in Styrofoam boxes along with
"cold packs" warmed to room temperature. The packages
were sent to each of the four clinical laboratories via same-
day air courier service in temperature-controlled compart-
ments, or for the second session, the packages were carried
in the passenger compartment by technicians. Processing
of the samples began simultaneously once after all of the
packages had arrived at these destinations.
PBMCs were isolated from each of the two aliquots. Cells
from the first aliquot were divided into two replicates, and
stimulated for measurement of cytokine secretion. ThePage 10 of 12
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shipped to Madison for cytokine analysis. Cells from the
second aliquot were divided into two replicates which
were cryopreserved and held at -80°C pending shipment
to Madison on dry ice. These replicates were thawed
within 2 weeks of receipt, and the cells were then stimu-
lated as described above.
Measurement of cytokines
Culture supernatants from fresh and frozen mononuclear
cells were assayed for various cytokines using the Bead-
lyte® Human Multi-Cytokine Flex Kit (Upstate, Lake
Placid, NY), a bead-based sandwich immunoassay. Proto-
col A of the manufacturer's instructions were followed,
and cytokines were quantified using the Luminex® 100™
instrument and IS 2.3 software (Luminex Corporation,
Austin, TX). Pilot study samples were obtained using BD
cytokine bead array (CBA) reagents (BD Biosciences, San
Jose, CA) according to manufacturer's protocol, acquired
on a BD LSR II and analyzed using BD CBA software.
Statistics and Analysis
For Figure 1, each cytokine was analyzed using a linear
mixed model [20] with individuals as random effects and
condition, stimulant, and day as fixed effects. All cytokine
measures were log-transformed to better meet the normal
distribution outcome assumption of the linear mixed
model. Heterogeneous variances for each condition were
determined using the likelihood ratio test. Estimation was
based on the method of restricted maximum likelihood
(REML). The mean difference, and its 95% confidence
interval, between cryopreserved (both constant rate
freezer and Nalgene freezer) and fresh PBMC cytokine
secretion was calculated for each combination of condi-
tion, stimulant, and day.
We assessed the quantitative differences between fresh vs.
cryopreserved samples from the same patient or from rep-
licates using two approaches: the Pearson correlation and
the concordance correlation 12. The Pearson correlation
measures a linear relationship, and the concordance cor-
relation measures the absolute level of agreement
between two methods in relation to the 45° identity line.
All analyses were performed using SAS software (SAS
Institute, Inc. Cary, NC). Figures were produced in R [21].
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